Actively Recruiting
Study of PET Imaging Using 68GaGa-DOTA-Cys-ATH001 to Detect PDGFR in Heart Fibrosis After Heart Attack or in Heart Failure Patients Compared to Healthy Adults
Led by Uppsala University · Updated on 2025-08-08
30
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying platelet derived growth factor receptor beta PDGFR, a marker linked to fibrotic heart changes, in people at high or low risk of heart failure after a specific type of heart attack called ST-Elevation Myocardial Infarction STEMI, as well as in patients with heart failure who have preserved ejection fraction HFpEF and healthy individuals. The study uses advanced imaging to explore PDGFR expression in the heart, aiming to better understand cardiac fibrosis and its development after heart injury. Participants are divided into four groups those at high risk of heart failure after STEMI, those at low risk after STEMI, patients with HFpEF showing heart failure signs, and healthy controls. Imaging is performed using PETMRI or separate PETCT and MRI scans with a special tracer called 68GaGa-DOTA-Cys-ATH001 that targets PDGFR. Groups with STEMI are scanned twice once one week after a stent procedure and again 2 to 8 months later. HFpEF patients and healthy volunteers have one scan after joining the study. During the study, participants undergo dynamic PET scans for heart blood flow, PDGFR tracer scans, and MRI scans to measure heart tissue changes. Researchers measure how the tracer binds in heart muscle and in damaged areas at the baseline and follow-up scans for STEMI groups. The study lasts from the initial scan through the follow-up period, with detailed imaging and assessments to observe changes over time. Safety and health status are monitored to ensure participant well-being throughout the study.
CONDITIONS
Brief Title
Platelet Derived Growth Factor Receptor ß (PDGFRß) Imaging in Cardiac Fibrosis
Research Team
K
Karl-Henrik Grinnemo, MD, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here